Search research articles
Contact Us
Filters
Showing results (91-100 of 337) with videos related to
Page
of 34
Sort By:
The Journal of Antimicrobial Chemotherapy
|
June 17, 2020
Pharmacokinetic similarity demonstrated after crushing of the elbasvir/grazoprevir fixed-dose combination tablet for HCV infection
Daniëlle W M Pijnenburg, Minou van Seyen, Evertine J Abbink, et al.
AIDS (London, England)
|
April 5, 2019
Carbamazepine intervention in a patient with efavirenz-induced liver injury
Tom G Jacobs, David M Burger, Arianna D Pranger, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 21, 2018
Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma
Pauline D J Bollen, Marga J A de Graaff-Teulen, Stein Schalkwijk, et al.
Clinical Pharmacology and Therapeutics
|
December 13, 2005
Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers
Rob E Aarnoutse, Johanneke Kleinnijenhuis, Peter P Koopmans, et al.
AIDS Care
|
December 22, 2009
Which method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?
Jeannine F J B Nellen, Pythia T Nieuwkerk, David M Burger, et al.
Plos One
|
July 26, 2024
First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020
Piter Oosterhof, Ferdinand W N M Wit, Matthijs van Luin, et al.
Antiviral Therapy
|
September 9, 2011
Selection of an M184V mutation in the cerebrospinal fluid of a treatment-naive HIV-infected individual starting darunavir-based therapy
Marion Cornelissen, Nicole K T Back, David M Burger, et al.
Antiviral Therapy
|
August 3, 2007
Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians
Joep J G van Oosterhout, Johnstone J Kumwenda, Michael Beadsworth, et al.
Clinical Pharmacokinetics
|
May 23, 2019
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update
Elise J Smolders, Anouk M E Jansen, Peter G J Ter Horst, et al.
Antiviral Therapy
|
March 4, 2014
Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration
Marieke Ezinga, Jack F M Wetzels, Marjolein E W Bosch, et al.
Page
of 34
Search research articles
Search
Showing results (91-100 of 337) with videos related to
Sort By:
Page
of 34
The Journal of Antimicrobial Chemotherapy
|
June 17, 2020
Pharmacokinetic similarity demonstrated after crushing of the elbasvir/grazoprevir fixed-dose combination tablet for HCV infection
Daniëlle W M Pijnenburg, Minou van Seyen, Evertine J Abbink, et al.
AIDS (London, England)
|
April 5, 2019
Carbamazepine intervention in a patient with efavirenz-induced liver injury
Tom G Jacobs, David M Burger, Arianna D Pranger, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 21, 2018
Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma
Pauline D J Bollen, Marga J A de Graaff-Teulen, Stein Schalkwijk, et al.
Clinical Pharmacology and Therapeutics
|
December 13, 2005
Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers
Rob E Aarnoutse, Johanneke Kleinnijenhuis, Peter P Koopmans, et al.
AIDS Care
|
December 22, 2009
Which method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?
Jeannine F J B Nellen, Pythia T Nieuwkerk, David M Burger, et al.
Plos One
|
July 26, 2024
First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020
Piter Oosterhof, Ferdinand W N M Wit, Matthijs van Luin, et al.
Antiviral Therapy
|
September 9, 2011
Selection of an M184V mutation in the cerebrospinal fluid of a treatment-naive HIV-infected individual starting darunavir-based therapy
Marion Cornelissen, Nicole K T Back, David M Burger, et al.
Antiviral Therapy
|
August 3, 2007
Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians
Joep J G van Oosterhout, Johnstone J Kumwenda, Michael Beadsworth, et al.
Clinical Pharmacokinetics
|
May 23, 2019
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update
Elise J Smolders, Anouk M E Jansen, Peter G J Ter Horst, et al.
Antiviral Therapy
|
March 4, 2014
Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration
Marieke Ezinga, Jack F M Wetzels, Marjolein E W Bosch, et al.
Page
of 34